Blog

Read our latest updates.

Unleashing the power of AI on rare disease drug discovery

Caleigh Findley, PhD | May 23, 2023

How the Rarebase Function product engine maximizes efficiency in rare disease drug discovery

Caleigh Findley, PhD | Apr 25, 2023

Rarebase Remarks Episode #5 - Joe Bellucci: High-throughput screening for drug discovery

3,700 disease-causing genes: Our plan to fill the void in rare disease drug discovery

Caleigh Findley, PhD | Feb 28, 2023

Reimagining rare disease research: The science & technology behind Rarebase

Caleigh Findley, PhD | Feb 27, 2023

How does Rarebase identify drug candidates for rare genetic diseases?

Brittany Anderton, PhD | Jan 24, 2023

Rarebase Remarks Episode #4 - Clayton Mellina: Engineering and AI in the biotech space

Onno Faber Selected for Worth Magazine’s Worthy 100 2022 List

Caleigh Findley, PhD | Dec 12, 2022

Video: Filling The Research Void For Rare Diseases (Techonomy)

Techonomy | Nov 29, 2022

Rarebase Is on the Hunt for Therapeutic Opportunities (Illumina)

Illumina | Oct 31, 2022

He Got A Rare Disease Diagnosis So He Rethought The Whole System (Worth)

Worth | Sep 12, 2022

Video: Drug discovery for rare diseases

Celebrating Our Second Anniversary

Fundraising best practices for rare disease foundations

Brittany Anderton, PhD | Jul 20, 2022

Using mathematics to provide a rare disease roadmap

Brittany Anderton, PhD | Jun 27, 2022

Rarebase Remarks Episode #2 - Chris Moxham: Drug hunting for rare disease

A path forward, for one or for many

Onno Faber | Feb 28, 2022

Rarebase Remarks Episode #1 – Lynsey Chediak: Never give up

The Champion for Rare Disease Cures (neo.life)

Neo.life | Sep 27, 2021

Rarebase launches a neuroscience drug discovery platform collaborating with 15 rare disease patient organizations

Lynsey Chediak | Sep 14, 2021

What does it mean to find a “cure” for a disease?

Onno Faber | Aug 03, 2021

It’s Monday. It’s still Rare Disease Day.

Onno Faber | Feb 26, 2021

Translating science into therapies, for one or for many.

Onno Faber | Nov 19, 2020